We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
CD134 antibody (Ber-ACT35) [PE]
Tumor necrosis factor receptor superfamily member 4
ACT35 antigen
OX40L receptor
TAX transcriptionally-activated glycoprotein 1 receptor
CD_antigen: CD134
Gene name: TNFRSF4, TXGP1L
ACT35 antigen
OX40L receptor
TAX transcriptionally-activated glycoprotein 1 receptor
CD_antigen: CD134
Gene name: TNFRSF4, TXGP1L
As low as
$484.50
In stock
Ref
00114398
CD134 antibody (Ber-ACT35) [PE]
| ID Covalab | mab20650 |
|---|---|
| Product type | Primary antibodies |
| Clonality | Monoclonal antibody |
| Clone | Ber-ACT35 |
| Isotype | IgG1 |
| Raised in | Mouse |
| Immunogen | HTLV 1-transformed HUT-102 cells |
| Activity cross reaction | Reacts with human CD134. Cross-reacts with monkey protein. |
| Species | Hu, Mk |
| Labelling | PE |
| Form | Purified (liquid chromatography) |
| Preservative | NaN3 15 mM |
| Storage instructions | Store in the dark at 2-8°C. Do not freeze. Avoid prolonged exposure to light. |
| Target | CD134 |
| Uniprot ID | P43489 |
| Gene ID | 7293 |
| Applications | ELISA, FC, IHC, IP, WB |
| Working dilutions | Optimal dilutions should be determined by the end user. The following are guidelines only: FC (10 µl for 100 µl of whole blood or 10^6 cells in suspension) |
| Publication | * Voo KS et al. Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function. J Immunol. 2013 Oct 1,191(7):3641-50. * Tanijiri T et al. Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells. J Leukoc Biol. 2007 Sep,82(3):576-84. * Willett BJ et al. Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus. J Virol. 2006 Apr;80(7):3386-94. * Endl J et al. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes. Diabetes. 2006 Jan,55(1):50-60. * Li M, Zhang Y. The effect of anti-human CD134 monoclonal antibody on phytohemagglutinin-induced mRNA expression of perforin in peripheral blood mononuclear cells. Cell Mol Immunol. 2005 Dec,2(6):467-71. * Aten J et al. Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol. 2000 Aug,11(8):1426-38. * Jones D et al. The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma. Blood. 1999 May 15,93(10):3487-93. |
Write Your Own Review